ChemoCentryx (NASDAQ:CCXI) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ChemoCentryx missed estimated earnings by 83.33%, reporting an EPS of $-0.55 versus an estimate of $-0.3.
Revenue was down $4.89 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 16.67% drop in the share price the next day.
Here's a look at ChemoCentryx's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.50 | -0.45 | -0.54 | -0.40 |
| EPS Actual | -0.58 | -0.32 | -0.56 | -0.43 |
| Revenue Estimate | 11.62M | 13.48M | 4.85M | 7.93M |
| Revenue Actual | 2.31M | 17.74M | 1.81M | 10.35M |
To track all earnings releases for ChemoCentryx visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
